KRAS and cancer: However, upon chronic inflammation and injury or sustained oncogenic activation of the small GTPase KRas, ADM can become persistent and result in the formation of pancreatic neoplasia and cancer (Guerra et al, 2007, 2011; Ji et al, 2009; Kong et al, 2018).